Top Markets
#1 Islamic Coin Islamic Coin +151.50%
#2 Akedo Akedo +48.58%
#3 DOVU DOVU +47.59%
#4 Velvet Velvet +38.22%
#5 Black Phoenix Black Phoenix +34.27%
#6 Cross Cross +19.42%
#7 DoubleZero DoubleZero +17.37%
#8 Cap Cap +16.79%
#9 Tutorial Tutorial +15.74%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.89%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Diagonal Bio AB (publ) Diagonal Bio AB (publ)

Diagonal Bio AB (publ)

DIABIO
Clasificación en acciones #40960
Diagonal Bio AB is a Swedish biotechnology firm dedicated to advancing the... Diagonal Bio AB is a Swedish biotechnology firm dedicated to advancing the Panviral platform. This innovative technology is engineered to pinpoint and diagnose minute genetic fragments belonging to a range of pathogens, such as viruses, bacteria, and fungi. Established in 2020, the company's main operations are based in Lund, Sweden.
Precio por acción
$0.00143282
Última sincronización: 2025-04-14
Capitalización bursátil
$57.28K
Cambio (1 día)
0.03%
Cambio (1 año)
0.00%
País
SE
Comercio Diagonal Bio AB (publ) (DIABIO)

Categoría

Healthcare
Ganancias de Diagonal Bio AB (publ) (DIABIO)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Diagonal Bio AB (publ), gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Diagonal Bio AB (publ) desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE